journal
MENU ▼
Read by QxMD icon Read
search

Pharmaceutical Patent Analyst

journal
https://www.readbyqxmd.com/read/29676653/tissue-targeted-nanocapsids-for-oral-insulin-delivery-via-drink
#1
Chun C Chen, Mo A Baikoghli, R Holland Cheng
For the past eight decades, subcutaneous injection has been the main route used for supplementing the suboptimal insulin secretion for administering insulin as a treatment for diabetes mellitus. Although this method is effective, subcutaneous injections are painful, inconvenient and carry a high risk of infections leading to poor patient compliance. The insulin-encapsulated hepatitis E virus nanoparticle, composed of the noninfectious hepatitis E viral capsid, is expected to deliver insulin from the GI tract to the liver after ingestion...
April 20, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29676211/patent-highlights-from-december-2017-to-january-2018
#2
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
April 20, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29629839/advances-in-patented-interpenetrating-polymeric-networks-for-biomedical-applications
#3
Pradeep Kumar, Yahya E Choonara, Lisa C du Toit, Viness Pillay
No abstract text is available yet for this article.
April 9, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29629820/recent-gene-delivery-patents-for-treatment-of-atherosclerosis
#4
Ambikanandan Misra
No abstract text is available yet for this article.
April 9, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29629817/trends-in-patented-chromones-for-skin-diseases
#5
Maria J Matos
No abstract text is available yet for this article.
April 9, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29553304/patenting-of-polymorphs
#6
Runjhun Tandon, Nitin Tandon, Rajesh Kumar Thapar
No abstract text is available yet for this article.
March 19, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29553297/experimental-data-required-to-support-second-medical-use-claims
#7
Jacqueline Satchell, Janelle Borham
The timing of filing a new patent application always requires a judgment call to be made between securing the earliest filing date and waiting to collect enough data to ensure the claims are fully supported and enabled across their scope. In addition, it is important to ensure that the application is drafted in such a way that it is suitable for filing in various jurisdictions. The case law we have considered for the sufficiency/enablement of second medical use claims in Europe, the USA and Australia makes it clear that experimental results should be included in the application at filing, and that the results must demonstrate that the claimed pharmaceutical product could be reasonably expected to treat the claimed indication...
March 19, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29553290/brexit-and-uk-market-exclusivities
#8
Peter Norman
No abstract text is available yet for this article.
March 19, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29417888/prior-art-takes-new-shapes-relying-on-non-traditional-prior-art-to-invalidate-a-patent
#9
MaryAnne Armstrong
No abstract text is available yet for this article.
March 1, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29417883/patent-highlights-october-november-2017
#10
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
March 1, 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29227204/canada-s-supreme-court-abolishes-promise-of-the-patent
#11
John Norman, Alex Gloor
The Supreme Court of Canada has done away with the 'promise of the patent' doctrine. This doctrine invalidated patents to numerous otherwise useful inventions from 2005 to 2016. The Supreme Court of Canada has clarified that the statutory utility requirement requires only a scintilla of utility related to the subject matter of the invention. This utility must have been demonstrated or soundly predicted as of the Canadian filing date. The decision brings increased certainty to Canada's patent system and more closely aligns it with international norms...
January 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29227203/therapeutic-charm-of-quercetin-and-its-derivatives-a-review-of-research-and-patents
#12
Ajay Sharma, Dharambir Kashyap, Katrin Sak, Hardeep Singh Tuli, Anil K Sharma
Bioactive polyphenolic compounds derived from plants are being utilized for prevention of various chronic diseases including cancer and cardiovascular disorders. Quercetin, a potential poly-phenolic flavonol, found in onions, apples and berries, has been implicated against cancer proliferation, chronic inflammation and various other oxidative manifestations. Evidences suggested that quercetin negatively regulates the numerous crucial signaling pathways associated with life-threatening diseases. Major signaling pathways including NF-κB, MAPK, PI3K-AKT and mTOR are found to be regulated by quercetin...
January 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29227198/novel-platinum-compounds-and-nanoparticles-as-anticancer-agents
#13
Arindam Sarkar
Since the approval of cisplatin in 1979, platinum-based drugs have been regularly used in cancer chemotherapy as a first-line treatment or with the combination of other nonplatinum drugs. Subsequent approval of second- and third-generation drugs such as carboplatin and oxaliplatin respectively, has widened the therapeutic achievement of platinum compounds. There are few other platinum drugs approved recently and many other new drugs as well as the formulations of the old ones are going through clinical trials now...
January 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29227196/immunotherapeutics-for-the-treatment-of-prostate-cancer-a-patent-landscape-based-on-key-therapeutic-mechanisms-of-actions
#14
Elaine Harris
The area of immunotherapeutics for the treatment of metastatic castrate-resistant prostate cancer has made significant progress since the autologous cell-based vaccine sipuleucel T became the first and to date only immunotherapy for its treatment. This review focuses on a broad patent landscaping exercise of this therapeutic area and considers if basing this landscaping on key mechanisms of action is appropriate to elicit the main patenting trends.
January 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29219751/patent-highlights-august-september-2017
#15
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
January 2018: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29064350/patenting-the-microbiome-trends-challenges-and-insights
#16
Anthony D Sabatelli, Nicholas G Vincent, David E Puleo
No abstract text is available yet for this article.
November 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29022759/no-change-in-scope-for-extension-of-patent-term-for-pharmaceutical-substances-under-australian-law-an-update
#17
Malcolm Lyons, Amanda Stark
No abstract text is available yet for this article.
November 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29022490/the-german-federal-supreme-court-also-granted-a-compulsory-patent-license-for-the-first-time-in-its-history
#18
Takeshi S Komatani
No abstract text is available yet for this article.
November 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29022415/doctrine-of-equivalents-in-japan-criteria-of-special-conditions-and-estoppel-final-conclusion
#19
Takeshi S Komatani
No abstract text is available yet for this article.
November 2017: Pharmaceutical Patent Analyst
https://www.readbyqxmd.com/read/29064331/patent-highlights-june-july-2017
#20
Hermann Am Mucke
A snapshot of noteworthy recent developments in the patent literature of relevance to pharmaceutical and medical research and development.
October 24, 2017: Pharmaceutical Patent Analyst
journal
journal
47821
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"